(AVIR) Atea Pharmaceuticals - Performance -29.8% in 12m
Compare AVIR with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-87.66%
#156 in Group
Rel. Strength
24.99%
#5969 in Universe
Total Return 12m
-29.77%
#100 in Group
Total Return 5y
-90.90%
#145 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -65.48%
5th Percentile in Group
12m Total Return: AVIR (-29.8%) vs XLV (-4.1%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
1.26% | 181% | 420% | 58.1 | 44.4 | 0.61 | 48.6% | 9.63% |
| LLY NYSE Eli Lilly |
3.47% | -2.41% | 404% | 67 | 36.6 | 1.33 | 58.2% | 18.9% |
| NVS NYSE Novartis |
8.01% | 14.6% | 64.6% | 17.9 | 13.9 | 1.36 | 8.40% | 9.2% |
| NOVN SW Novartis |
2.79% | 4.23% | 40.3% | 19.3 | 13.9 | 1.32 | 9.80% | 11.2% |
| SOBI ST Swedish Orphan Biovitrum |
12% | 5.01% | 48.3% | 25.6 | 20.9 | 1.61 | 16.1% | 29% |
| SAN PA Sanofi |
-1.52% | 2.67% | 20.4% | 19.2 | 11.7 | 0.88 | -16.5% | 12.2% |
| IPN PA Ipsen |
1.81% | -12.6% | 57.8% | 23.3 | 9.65 | 0.69 | -6.40% | -6.33% |
| SUPN NASDAQ Supernus Pharmaceuticals |
2.94% | 0.77% | 35.3% | 24.6 | 20.2 | 1.47 | -5.90% | -17% |
Performance Comparison: AVIR vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for AVIR
| Total Return (including Dividends) | AVIR | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 4.15% | 0.87% | 13.81% |
| 3 Months | -9.21% | -7.96% | -6.30% |
| 12 Months | -29.77% | -4.06% | 10.65% |
| 5 Years | -90.90% | 43.49% | 107.77% |
| Trend Score (consistency of price movement) | AVIR | XLV | S&P 500 |
| 1 Month | 21.0% | -8.1% | 83% |
| 3 Months | -59.8% | -75.3% | -75.3% |
| 12 Months | -83.2% | -28.8% | 50.1% |
| 5 Years | -90.0% | 89.7% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #86 | 3.25% | -8.49% |
| 3 Month | #57 | -1.36% | -3.11% |
| 12 Month | #101 | -26.8% | -36.5% |
| 5 Years | #145 | -93.6% | -95.1% |
FAQs
Does AVIR Atea Pharmaceuticals outperforms the market?
No,
over the last 12 months AVIR made -29.77%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.06%.
Over the last 3 months AVIR made -9.21%, while XLV made -7.96%.
Over the last 3 months AVIR made -9.21%, while XLV made -7.96%.
Performance Comparison AVIR vs Indeces and Sectors
AVIR vs. Indices AVIR is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -8.87% | -9.66% | -16.2% | -40.4% |
| US NASDAQ 100 | QQQ | -9.06% | -13.2% | -16.4% | -41.4% |
| US Dow Jones Industrial 30 | DIA | -9.28% | -5.84% | -15.9% | -37.5% |
| German DAX 40 | DAX | -8.85% | -10.8% | -42.5% | -55.5% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -11.1% | -7.68% | -17.0% | -37.1% |
| Hongkong Hang Seng | HSI | -12.0% | -15.8% | -24.6% | -43.5% |
| India NIFTY 50 | INDA | -3.95% | -0.69% | -16.6% | -29.6% |
| Brasil Bovespa | EWZ | -9.92% | -13.1% | -24.9% | -21.4% |
AVIR vs. Sectors AVIR is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -9.51% | -9.26% | -23.3% | -51.3% |
| Consumer Discretionary | XLY | -9.25% | -10.1% | -15.2% | -44.0% |
| Consumer Staples | XLP | -8.01% | -2.44% | -23.1% | -38.9% |
| Energy | XLE | -8.69% | -2.61% | -9.61% | -20.3% |
| Financial | XLF | -9.97% | -9.37% | -23.3% | -52.2% |
| Health Care | XLV | -5.86% | 3.28% | -11.2% | -25.7% |
| Industrial | XLI | -10.6% | -12.7% | -17.6% | -40.8% |
| Materials | XLB | -8.67% | -9.41% | -11.3% | -24.5% |
| Real Estate | XLRE | -7.55% | -7.39% | -17.0% | -45.2% |
| Technology | XLK | -9.95% | -17.1% | -13.3% | -36.9% |
| Utilities | XLU | -8.92% | -5.44% | -23.9% | -47.2% |
| Aerospace & Defense | XAR | -10.9% | -17.0% | -27.7% | -57.1% |
| Biotech | XBI | -2.28% | -7.66% | 3.94% | -17.5% |
| Homebuilder | XHB | -9.34% | -7.33% | -3.01% | -22.2% |
| Retail | XRT | -10.8% | -10.5% | -12.0% | -28.3% |